Citizens

CIA · NYSE

$3.53+$0.08 (+2.32%)TodayMarket closed ·
Prev close $3.45

About CIA

Citizens, Inc. is a holding company, which engages in the provision of insurance and reinsurance services. The company is headquartered in Austin, Texas and currently employs 243 full-time employees. The company operates two segments: Life Insurance and Home Service Insurance. The Life Insurance segment sells U.S. dollar-denominated whole life insurance, endowment and critical illness policies to non-U.S. residents, located principally in Latin America and the Pacific Rim. In the U.S. it primarily sells whole-life final expense insurance and insurance with living benefits. This segment operates business through CICA Life, A.I. (CICA International) and CICA Life Insurance Company of America (CICA Domestic). The Home Service Insurance segment offers affordable life insurance policies to lower-income households in Louisiana, Mississippi and Arkansas, conducting business through Security Plan Life Insurance Company and Magnolia Guaranty Life Insurance Company.

Employees
245
Headquarters
Austin, Texas
Listed
Dec 4, 1980
Sector
Financials
Industry
Insurance

CIA key statistics

Market cap
178.77M
Price-earnings ratio
16.43
Dividend yield
—
Average volume
106.01K
Volume
124.96K
Open price
$3.45
High today
$3.60
Low today
$3.37
52 Week high
$6.54
52 Week low
$3.31

Citizens (CIA) at a glance

Citizens (CIA) last traded at $3.53, with a market cap of 178.77M and a price-to-earnings ratio of 16.43.

Today the stock has traded between $3.37 and $3.60. The current price is 4.9% above the day's low and 1.9% below its high.

Volume so far is 124.96K shares, in line with the average of 106.01K shares a day.

Over the past year Citizens has ranged from $3.31 to $6.54, and now sits 7% of the way up that range.

Citizens met or beat analyst EPS estimates in 2 of the last 8 quarters. In Q2 FY26 it reported -$0.01 per share against an estimate of $0.0707.

The average analyst price target is $5.36, 51.7% above the current price, from 1 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

100%of 1 analyst rating say Buy
  • Buy100.0%
  • Hold0.0%
  • Sell0.0%
Price target · 3 analystsAvg $5.36
Low
$5.05
Now
$3.53
High
$5.78

CIA earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 2 of the last 8 quarters, by 147.5% on average.

  1. Q3 FY24: reported $0.05 per share against an estimate of $0.0808
  2. Q4 FY24: reported $0.07 per share against an estimate of $0.096
  3. Q1 FY25: reported -$0.03 per share against an estimate of $0.0505
  4. Q2 FY25: reported $0.13 per share against an estimate of $0.0404
  5. Q3 FY25: reported $0.04 per share against an estimate of $0.0606
  6. Q4 FY25: reported $0.14 per share against an estimate of $0.0808
  7. Q1 FY26: reported $0.03 per share against an estimate of $0.0505
  8. Q2 FY26: reported -$0.01 per share against an estimate of $0.0707

CIA news

  • 10 Financials Stocks With Whale Alerts In Today's Session

  • Press releaseNewsfile

    Citizens, Inc. Reports Full Year and Fourth Quarter 2024 Financial Results

  • Press releaseNewsfile

    Citizens, Inc. Reports Third Quarter 2024 Financial Results

  • Press releaseBusiness Wire

    AM Best Affirms Credit Ratings of CICA Life Insurance Company of America

  • Press releaseNewsfile

    Citizens, Inc. Reports Second Quarter 2024 Financial Results

  • Avi Kapoor

    Citizens And 4 Other Stocks Under $5 Insiders Are Buying

Similar companies

Companies in the same industry as Citizens

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.